Back
Tarsus Pharmaceuticals Stock Predictions

Invest Where Innovation Meets Real Demand
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
41
TARS
Tarsus Pharmaceuticals
Last Price:
$43.05
Seasonality Move:
1.77%
7 Day Trial
ALL ACCESS PASS
$
7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioTarsus Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Tarsus Pharmaceuticals has on average historically risen by 36.2% based on the past 4 years of stock performance.
-
Tarsus Pharmaceuticals has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Tarsus Pharmaceuticals Stock Undervalued?The current Tarsus Pharmaceuticals [TARS] share price is $42.98. The Score for TARS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TARS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Tarsus Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Tarsus Pharmaceuticals has on average historically risen by 36.2% based on the past 4 years of stock performance.
Tarsus Pharmaceuticals Stock Rating
Sell
41
Tarsus Pharmaceuticals (TARS)
is a Sell
Is Tarsus Pharmaceuticals overpriced?
-
Tarsus Pharmaceuticals has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Tarsus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
tarsusrx.com
52-Week Data
52-Week High:
57.28
52-Week Low:
20.08
Prediction Charts
Market Cap:
1.8B
Price in USD:
42.98
Volume:
324.2K
Beta:
0.94
Technical Analysis
SMA50:
47.76
SMA100:
48.65
SMA200:
43.83
52-Wk Change:
18.86%
Stock Predictions
-
Is Tarsus Pharmaceuticals stock public?Yes, Tarsus Pharmaceuticals is a publicly traded company.
-
What is the Tarsus Pharmaceuticals stock quote today?The Tarsus Pharmaceuticals stock price is 42.98 USD today.
-
How to buy Tarsus Pharmaceuticals stock online?You can buy Tarsus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-6 | 47.78 | 46.45 | 48.16 | 45.78 |
May-7 | 46.74 | 47.35 | 48.32 | 45.91 |
May-8 | 47.95 | 47.14 | 48.00 | 46.44 |
May-9 | 47.11 | 44.76 | 47.32 | 44.60 |
May-12 | 45.13 | 44.20 | 46.25 | 44.12 |
May-13 | 44.16 | 41.46 | 44.16 | 40.78 |
May-14 | 41.82 | 42.90 | 43.12 | 40.38 |
May-15 | 43.20 | 43.50 | 43.95 | 41.88 |
May-16 | 43.50 | 43.70 | 44.79 | 43.50 |
May-19 | 43.66 | 45.01 | 45.17 | 43.43 |
May-20 | 44.93 | 44.88 | 45.18 | 44.59 |
May-21 | 44.88 | 43.19 | 45.48 | 43.06 |
May-22 | 43.00 | 42.97 | 43.73 | 42.59 |
May-23 | 42.90 | 42.98 | 43.23 | 42.47 |
Tarsus Pharmaceuticals Earnings
Tarsus Pharmaceuticals Earnings Report: Per Share Tarsus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Tarsus Pharmaceuticals Forecast Revenue Growth
Tarsus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Tarsus Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $1.02 per share, an increase this year of $2.22 per share, and an increase next year of $2.11 per share.
* Tarsus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.